Liposomes with triggered content release for cancer therapy

Ali M. Alaouie, Stavroula Sofou

Research output: Contribution to journalArticlepeer-review


Cancer currently accounts for 13 percent of worldwide deaths. This could be largely attributed to limited effectiveness of conventional drug delivery methods resulting in reduced accumulation of therapeutics at tumor sites compared to healthy organs, and in low drug bioavailability. Nanocarriers capable of effectively improving localization, accumulation, and release of therapeutic agents at the tumors could become the preferred drug transport strategy for the therapy of several types of cancer. Liposomal nanocarriers, in particular, have attracted considerable interest. The release mechanisms of entrapped anticancer agents from liposomes rely mostly on applying our understanding of the physical behavior of lipid membranes to engineer successful solutions. In this review, we intend to provide some insight into the different triggers and different mechanisms of membrane destabilization that are currently pursued to result in effective content release.

Original languageEnglish (US)
Pages (from-to)234-244
Number of pages11
JournalJournal of Biomedical Nanotechnology
Issue number3
StatePublished - Sep 2008
Externally publishedYes


  • BNCT
  • Enzyme activated liposome release
  • Heat activated liposome release
  • pH activated liposome release
  • Triggerable liposomes
  • Ultrasound activated liposome release
  • UV activated liposome release

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • General Materials Science
  • Pharmaceutical Science


Dive into the research topics of 'Liposomes with triggered content release for cancer therapy'. Together they form a unique fingerprint.

Cite this